PubMed · 12969496
Genetically modified filamentous phage as bactericidal agents: a pilot study.
Abstract
AIMS: To evaluate the ability of a filamentous phage encoding lethal proteins to kill bacteria without host-cell lysis. METHODS AND RESULTS: Bacterial survival was determined after infection of a growing Escherichia coli culture with phage M13 encoding either the restriction endonuclease BglII gene or modified phage lambda S holin genes. The genetically engineered phage exerted a high killing efficiency while leaving the cells structurally intact. When compared with a lytic phage, the release of endotoxin was minimized after infection with the genetically modified phages. CONCLUSIONS: Genetically engineered phage can be used for efficient killing, concomitantly minimizing endotoxin release. SIGNIFICANCE AND IMPACT OF THE STUDY: This feasibility study provides a possible strategy for the use of genetically engineered phage as bactericidal agents by optimizing the advantages and minimizing potential risks such as release of pyrogenic cell wall components.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
S Hagens, U Bläsi. 2003. Genetically modified filamentous phage as bactericidal agents: a pilot study.. https://doi.org/10.1046/j.1472-765x.2003.01400.x. https://pubmed.health/record/pubmed%3A12969496/genetically-modified-filamentous-phage-as-bactericidal-agents-a-pilot-study
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.